Tefron Statistics

Total Valuation

Tefron has a market cap or net worth of ILS 339.39 million. The enterprise value is 378.81 million.

Market Cap	339.39M
Enterprise Value	378.81M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.99%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.78M

Valuation Ratios

The trailing PE ratio is 5.73.

PE Ratio	5.73
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.21, with an EV/FCF ratio of 4.55.

EV / Earnings	6.39
EV / Sales	0.36
EV / EBITDA	3.21
EV / EBIT	4.15
EV / FCF	4.55

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.23.

Current Ratio	1.70
Quick Ratio	0.99
Debt / Equity	0.23
Debt / EBITDA	0.52
Debt / FCF	0.76
Interest Coverage	12.04

Financial Efficiency

Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 17.46%.

Return on Equity (ROE)	23.54%
Return on Assets (ROA)	10.83%
Return on Capital (ROIC)	17.46%
Revenue Per Employee	917,583
Profits Per Employee	50,042
Employee Count	1,184
Asset Turnover	2.00
Inventory Turnover	4.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.21% in the last 52 weeks. The beta is 1.10, so Tefron's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+63.21%
50-Day Moving Average	3,102.36
200-Day Moving Average	2,742.64
Relative Strength Index (RSI)	59.28
Average Volume (20 Days)	13,736

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	113.05

Income Statement

In the last 12 months, Tefron had revenue of ILS 1.09 billion and earned 59.25 million in profits. Earnings per share was 4.43.

Revenue	1.09B
Gross Profit	249.49M
Operating Income	94.33M
Pretax Income	77.13M
Net Income	59.25M
EBITDA	121.84M
EBIT	94.33M
Earnings Per Share (EPS)	4.43

Full Income Statement

Balance Sheet

The company has 22.59 million in cash and 63.29 million in debt, giving a net cash position of -40.70 million.

Cash & Cash Equivalents	22.59M
Total Debt	63.29M
Net Cash	-40.70M
Net Cash Per Share	n/a
Equity (Book Value)	279.20M
Book Value Per Share	22.36
Working Capital	168.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 109.52 million and capital expenditures -26.20 million, giving a free cash flow of 83.32 million.

Operating Cash Flow	109.52M
Capital Expenditures	-26.20M
Free Cash Flow	83.32M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.96%, with operating and profit margins of 8.68% and 5.45%.

Gross Margin	22.96%
Operating Margin	8.68%
Pretax Margin	7.10%
Profit Margin	5.45%
EBITDA Margin	11.22%
EBIT Margin	8.68%
FCF Margin	7.67%

Dividends & Yields

Tefron does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	12.52%
Buyback Yield	-4.99%
Shareholder Yield	-4.99%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 22, 2009
Split Type	Reverse
Split Ratio	0.1

Scores

Tefron has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a